| 000 | 01426cam a22003614a 4500 | ||
|---|---|---|---|
| 001 | 15125853 | ||
| 003 | KENaKMTC | ||
| 005 | 20130129085345.0 | ||
| 008 | 080102s2009 paua b 001 0 eng | ||
| 010 | _a 2008000008 | ||
| 016 | 7 |
_a101462649 _2DNLM |
|
| 020 | _a9780781774246 (alk. paper) | ||
| 020 | _a0781774241 (alk. paper) | ||
| 035 | _a(OCoLC)ocn187289462 | ||
| 040 |
_aDNLM/DLC _cDLC _dNLM _dBAKER _dYDXCP _dBTCTA _dC#P _dCDX _dDLC |
||
| 042 | _apcc | ||
| 050 | 0 | 0 | _aRM301.25.S693 2009 |
| 100 | 1 | _aSpilker, Bert. | |
| 245 | 1 | 0 |
_aGuide to drug development : _ba comprehensive review and assessment / _cBert Spilker. |
| 260 |
_aPhiladelphia : _bWolters Kluwer Health/Lippincott Williams & Wilkins, _cc2009. |
||
| 300 |
_axviii, 1277 p. : _bill. ; _c29 cm. |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 650 | 0 | _aDrug development. | |
| 650 | 1 | 2 | _aDrug Design. |
| 650 | 2 | 2 |
_aDrug Evaluation, Preclinical _xmethods. |
| 650 | 2 | 2 |
_aDrug Industry _xmethods. |
| 650 | 2 | 2 | _aPharmaceutical Preparations. |
| 856 | 4 | 1 |
_3Table of contents only _uhttp://www.loc.gov/catdir/toc/ecip088/2008000008.html |
| 856 | 4 | 2 |
_3Publisher description _uhttp://www.loc.gov/catdir/enhancements/fy0809/2008000008-d.html |
| 906 |
_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg |
||
| 942 |
_2lcc _cBK _xgnw |
||
| 999 |
_c3835 _d3835 |
||